1 min read|54 words
A Medicare beneficiary was hospitalized after her insurer delayed approval of a clinically necessary immune-boosting medication. Her case exposes a critical gap between the insurance industry's public pledges to reform prior authorization and real-world delays that harm patients. Read how administrative gatekeeping can escalate preventable complications.
Read the full article on GMJ Newsroom →
Was this article helpful?
